GMDP Global Medical Products Holdings Inc (CE)

HENDERSON, NV, March 5 /PRNewswire-FirstCall/ -- Global Medical Products Holdings, Inc. (GMDP; http://www.globalmedicalcorporation.com/) retained the Mina Mar Group Inc. (http://www.minamargroup.com/) retained Mina Mar Group (http://www.minamargroup.com/) as the lead merger representative for the company' expansive corporate interests. Mina Mar Group will lead the company as its head Merger Corporate Advisor and its affiliate company Mina Mar Marketing Group http://www.minamargroup.net/ will take over the Investor Relations (IR) tasks. The mandate is to represent GMDP' interests in public market, bringing the company closer to the investors' community. A source close to the company, said, "We remind our followers that GMDP is a company operating under the auspices of the court appointed guardian - custodian. We have posted a number of pdf documents on our corporate web site, http://www.globalmedicalcorporation.com/ and our IR web site "CLIENT SUPPORT" section. We ask our followers to review these documents, and in particular the document named General Company update dated March 3. This document is self explanatory. In preparation for the merger the company recently recapitalized its Authorized Share Structure to 2,000 Million Shares. The only currency the company has, are its restricted shares, and cash in a form of a loan or financing from its preferred shareholders or accredited investors. Usual process in the merger is that a company will need to be recapitalized to absorb the merger, and pay for the assets being acquired. Depending on the situation, sometimes both cash and shares are issued in the merger. Obviously, the higher the share price of our stock the less stock the company has to issue in the merger to the targeted merger company. This merger is being created whereby these shares will be held in escrow upon the merger and remain the control block for some time after the merger. The float and the free trading shares usually remains undisturbed after the merger. The shares these companies receive are subject to insiders and control block and referred to as Rule 144 stock, and are restricted shares; meaning they cannot trade; henceforth as aforementioned the float remains undisturbed after the merger. The company will shortly begin updating Pink Sheets with Adequate Disclosure, Updated Financials and report all relevant merger news. There is no reverse split, nor any toxic financing planned for the company. The company has made available sufficient funds and resources through its preferred shareholders and accredited investors to become a vibrant and operational company. On that note, on February 25 the company posted possible China merger candidates on its web site. This is a preliminary list. Our merger representative operates a back office for Directors and Officers of public companies who can log in and view and begin discussions with suitable candidates. So far GMDP is in discussions with a China based animal medical manufacturing company servicing this growing and expanding industry. Revenues and assets are in the 4 to 5 $ million dollar range. Immediate plans include representatives and CEO' from the targeted merger companies will find their way to the Mina Mar Group Shareholders' Conference on April 9, in Toronto where GMDP will be greeting its own shareholders and guests; for further discussions and a possible finalization of the merger transaction shortly thereafter. Again, merger transactions are a process and subject to change. The company reminds our shareholders and followers to monitor PinkSheets.com Filing Section and also our IR company web site section "CLIENT SUPPORT" TAB http://www.minamargroup.net/ or this direct link http://minamarmarketinggroup.helpserve.com/ for further updates on this and other business matters. Non-newsworthy events are not press released however posted on these two separate support sites to keep our followers advised of day-to-day events. For any matters relating to retail investor queries or to send us the company directly a message please click on the "INVESTOR SUPPORT" TAB or this direct link http://www.minamargroup.net/helpdesk. Don't be a victim. Take Control! Fight Back! Report a stock basher! The company is mindful that short sellers, the company competitors and stock bashers stalk small cap Pink Sheets listed companies with hidden agendas, where amongst other things they continuously spread false rumors, dark propaganda and innuendos in order to manipulate the trading patterns and thwart company plans for their own "quick profits" and self serving needs. The company and its supporters are monitoring these activities and those are promptly being reported on the http://www.stockbasher.com/web site. Visit http://www.stockbasher.com/and find out what criminal and civil actions the US authorities are taking against web sites like investorshub.com and other posters, and other media that provide safe refuge to these individuals and the remedies available to you as an individual investor. Filings for this event are currently being reviewed and will be filed with Pink Sheets and Client Support Section in due course. To be included in company's email database for press releases, industry updates, and non-weekly activity at the company that may or may not be news released, please subscribe or opt in mailer at http://www.minamargroup.com/updates. Safe Harbor Statement Information in this news release may contain statements about future expectations, plans, prospects or performance of Global Medical Products Holdings, Inc. that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be", "expects", "may affect", "believed", "estimate", "project" and similar words and phrases are intended to identify such forward-looking statements. Global Medical Products Holdings, Inc. cautions you that any forward-looking information provided by or on behalf of Global Medical Products Holdings, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. Global Medical Products Holdings, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Global Medical Products Holdings, Inc.'s control. In addition to those discussed in Global Medical Products Holdings, Inc.'s press releases, public filings, and statements by Global Medical Products Holdings, Inc.'s management, including, but not limited to, Global Medical Products Holdings, Inc.'s estimate of the sufficiency of its existing capital resources, Global Medical Products Holdings, Inc.'s ability to raise additional capital to fund future operations, Global Medical Products Holdings, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities, and in identifying contracts which match Global Medical Products Holdings, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Global Medical Products Holdings, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events. CONTACT: For any investor relations matters, please contact http://www.minamargroup.net/helpdesk; Investor Relations Department Inquiry, http://www.minamargroup.net/ (IR); For (M&A) and Corporate Matters, http://www.minamargroup.com/ DATASOURCE: Global Medical Products Holdings, Inc. CONTACT: For any investor relations matters, please contacthttp://www.minamargroup.net/helpdesk; Investor Relations Department Inquiry,http://www.minamargroup.net/ (IR); For (M&A) and Corporate Matters,http://www.minamargroup.com/

Copyright